Jane Street Group LLC Makes New Investment in ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO)

Jane Street Group LLC purchased a new position in shares of ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO) in the third quarter, according to its most recent filing with the SEC. The firm purchased 9,795 shares of the company’s stock, valued at approximately $366,000. Jane Street Group LLC owned 0.31% of ALPS Medical Breakthroughs ETF at the end of the most recent quarter.

Separately, Griffin Asset Management Inc. lifted its position in ALPS Medical Breakthroughs ETF by 31.2% in the 3rd quarter. Griffin Asset Management Inc. now owns 30,135 shares of the company’s stock valued at $1,125,000 after acquiring an additional 7,170 shares in the last quarter.

ALPS Medical Breakthroughs ETF Stock Down 1.9 %

Shares of NYSEARCA SBIO opened at $32.85 on Thursday. ALPS Medical Breakthroughs ETF has a fifty-two week low of $31.00 and a fifty-two week high of $42.73. The firm’s 50-day simple moving average is $36.89 and its 200 day simple moving average is $36.77.

ALPS Medical Breakthroughs ETF Profile

The ALPS Medical Breakthroughs ETF (SBIO) is an exchange-traded fund that is based on the S-Network Medical Breakthroughs index. The fund tracks, a market-cap weighted index comprising US-listed biotech companies with one or more drugs currently in either Phase II or Phase III FDA clinical trials. SBIO was launched on Dec 31, 2014 and is managed by ALPS.